Skip to Content

2017 Financial Releases

Keyword Search
 
2017 | 2016 | 2015 | 2014 | 2013
DateTitle 
05/24/17AbbVie to Present at the Goldman Sachs 38th Annual Global Healthcare Conference
NORTH CHICAGO, Ill., May 24, 2017 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Goldman Sachs 38th Annual Global Healthcare Conference on Tuesday, June 13, 2017. Bill Chase, executive vice president and chief financial officer, will present at 10 a.m. Central time. A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.     About AbbVi... 
Printer Friendly Version
05/19/17AbbVie to Present at the Jefferies 2017 Global Healthcare Conference
NORTH CHICAGO, Ill., May 19, 2017 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Jefferies 2017 Global Healthcare Conference on Thursday, June 8, 2017. Bill Chase, executive vice president and chief financial officer, will present at 1:30 p.m. Central time. A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.     About AbbVie AbbVie... 
Printer Friendly Version
05/05/17AbbVie to Present at the UBS Global Healthcare Conference
NORTH CHICAGO, Ill., May 5, 2017 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the UBS Global Healthcare Conference on Monday, May 22, 2017. Richard A. Gonzalez, chairman of the board and chief executive officer, will present at 7 a.m. Central time. A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.     About AbbVie AbbVie is a globa... 
Printer Friendly Version
04/27/17AbbVie Reports First-Quarter 2017 Financial Results
- Reports First-Quarter Diluted EPS of $1.06 on a GAAP Basis; Adjusted Diluted EPS of $1.28, Reflecting Growth of 11.3 Percent - Delivers First-Quarter Net Revenues of $6.538 Billion on a GAAP Basis, Reflecting Growth of 10.1 Percent on an Operational Basis - First-Quarter Global Humira Sales of $4.118 Billion Increased 15.1 Percent on a Reported Basis, or 15.8 Percent on an Operational Basis; First-Quarter U.S. Humira Sales of $2.696 Billion Increased 22.8 Percent - First-Quarter Globa... 
Printer Friendly Version
04/21/17AbbVie to Present at the Deutsche Bank 42nd Annual Health Care Conference
NORTH CHICAGO, Ill., April 21, 2017 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Deutsche Bank 42nd Annual Health Care Conference on Wednesday, May 3, 2017. William Chase, executive vice president and chief financial officer, will present at 7:40 a.m. Central time. A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.     About AbbV... 
Printer Friendly Version
04/06/17AbbVie to Host First-Quarter Earnings Conference Call
NORTH CHICAGO, Ill., April 6, 2017 /PRNewswire/ -- AbbVie (NYSE: ABBV) will announce its first-quarter 2017 financial results on Thursday, April 27, 2017, before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. Central time (9 a.m. Eastern). It will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the call will be available after 11 a.m. Central time. About AbbVie  AbbVie is a global, rese... 
Printer Friendly Version
03/01/17AbbVie to Present at the Barclays Global Healthcare Conference
NORTH CHICAGO, Ill., March 1, 2017 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Barclays Global Healthcare Conference on Wednesday, March 15, 2017. William Chase, executive vice president and chief financial officer, will present at 8 a.m. Central time. A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations website at www.investors.abbvie.com. An archived edition of the session will be available later that day.     About AbbVie AbbV... 
Printer Friendly Version
02/17/17AbbVie Announces $5 Billion Increase to Stock Repurchase Program
NORTH CHICAGO, Ill., Feb. 17, 2017 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) has authorized a $5 billion increase to AbbVie's existing stock repurchase program. Purchases may be made from time to time in management's discretion. The stock repurchase authorization permits shares to be repurchased in open market or private transactions, has no time limit and may be discontinued at any time. About AbbVie AbbVie is a global, research-based biopharmaceutical company ... 
Printer Friendly Version
02/16/17AbbVie Declares Quarterly Dividend
NORTH CHICAGO, Ill., Feb. 16, 2017 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) declared a quarterly cash dividend of $0.64 per share.  The cash dividend is payable May 15, 2017 to stockholders of record at the close of business on April 13, 2017. Since the company's inception in 2013, AbbVie has increased its dividend by 60 percent.  AbbVie is a member of the S&P Dividend Aristocrats Index, which tracks companies that have annually increased their div... 
Printer Friendly Version
02/15/17AbbVie to Present at the Cowen and Company 37th Annual Health Care Conference
NORTH CHICAGO, Ill., Feb. 15, 2017 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Cowen and Company 37th Annual Health Care Conference on Wednesday, March 8, 2017. William Chase, executive vice president and chief financial officer, will present at 8:20 a.m. Central time. A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.     About... 
Printer Friendly Version
01/27/17AbbVie Reports Full-Year and Fourth-Quarter 2016 Financial Results
- Reports Full-Year Diluted EPS of $3.63 on a GAAP Basis; Adjusted Diluted EPS of $4.82, Reflecting Growth of 12.4 Percent - Delivers Full-Year Net Revenues of $25.638 Billion on a GAAP Basis; Adjusted Net Revenues of $25.560 Billion Grew 13.3 Percent on an Operational Basis - Full-Year Global Humira Sales of $16.078 Billion Increased 16.1 Percent on an Operational Basis - Full-Year Global IMBRUVICA Net Revenues Exceeded $1.8 Billion - Reports Fourth-Quarter Diluted EPS of $0.85 on a... 
Printer Friendly Version
01/10/17AbbVie to Host Fourth-Quarter 2016 Earnings Conference Call
NORTH CHICAGO, Ill., Jan. 10, 2017 /PRNewswire/ -- AbbVie (NYSE: ABBV) will announce its Fourth-Quarter 2016 financial results on Friday, January 27, 2017. AbbVie will host a live webcast of the earnings conference call at 8 a.m. Central time (9 a.m. Eastern). It will be accessible through AbbVie's Investor Relations website http://investors.abbvie.com. An archived edition of the session will be available later that day. About AbbVie AbbVie is a global, research-based biopharmaceutical c... 
Printer Friendly Version